146 related articles for article (PubMed ID: 19708940)
21. Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: a study of 48 cases.
Chatzipantelis P; Salla C; Konstantinou P; Karoumpalis I; Sakellariou S; Doumani I
Cancer; 2008 Aug; 114(4):255-62. PubMed ID: 18618505
[TBL] [Abstract][Full Text] [Related]
22. Endocrine tumors of the duodenum. A study of 55 cases relative to clinicopathological features and hormone content.
Heymann MF; Hamy A; Triau S; Miraillé E; Toquet C; Chomarat H; Cohen C; Maitre F; Le Bodie MF
Hepatogastroenterology; 2004; 51(59):1367-71. PubMed ID: 15362754
[TBL] [Abstract][Full Text] [Related]
23. Biochemical diagnosis of neuroendocrine GEP tumor.
Oberg K
Yale J Biol Med; 1997; 70(5-6):501-8. PubMed ID: 9825477
[TBL] [Abstract][Full Text] [Related]
24. [Liver transplantation in neuroendocrine tumors prolongs symptom-free period, might also be a cure].
Olausson M; Friman S; Johanson V; Nilsson O; Wängberg B; Ahlman H
Lakartidningen; 1999 Sep; 96(36):3783-6. PubMed ID: 10500396
[TBL] [Abstract][Full Text] [Related]
25. Serine protease inhibitor 8 is a novel immunohistochemical marker for neuroendocrine tumors of the pancreas.
de Koning PJ; Bovenschen N; Broekhuizen R; Lips CJ; Kummer JA
Pancreas; 2009 May; 38(4):461-7. PubMed ID: 19188865
[TBL] [Abstract][Full Text] [Related]
26. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery in advanced endocrine tumours of the pancreas.
Pederzoli P; Falconi M; Bonora A; Salvia R; Sartori N; Contro C; Marcucci S; Bassi C
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S207-12. PubMed ID: 10604132
[TBL] [Abstract][Full Text] [Related]
28. Nonfunctioning neuroendocrine tumors of the pancreas: clinical presentation of 7 patients.
Closset J; Delhaye M; Sperduto N; Rickaert F; Gelin M
Hepatogastroenterology; 1996; 43(12):1640-4. PubMed ID: 8975980
[TBL] [Abstract][Full Text] [Related]
29. NKX6-1 Is a Novel Immunohistochemical Marker for Pancreatic and Duodenal Neuroendocrine Tumors.
Tseng IC; Yeh MM; Yang CY; Jeng YM
Am J Surg Pathol; 2015 Jun; 39(6):850-7. PubMed ID: 25871618
[TBL] [Abstract][Full Text] [Related]
30. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
Qiu W; Christakis I; Silva A; Bassett RL; Cao L; Meng QH; Gardner Grubbs E; Zhao H; Yao JC; Lee JE; Perrier ND
Clin Endocrinol (Oxf); 2016 Sep; 85(3):400-7. PubMed ID: 27256431
[TBL] [Abstract][Full Text] [Related]
31. [Neuroendocrine tumors of the digestive system].
Prónai L; Rácz K; Tulassay Z
Orv Hetil; 2002 May; 143(19 Suppl):1081-6. PubMed ID: 12063866
[TBL] [Abstract][Full Text] [Related]
32. [Gastrin-secreting neuroendocrine carcinoma: two cases identified and treated surgically with a radio-guided technique].
Pandolfi U; Cossard D; Pesenti Campagnoni A; Biandrate F; Piccolini M; Francia L; Zadra F; Ambrosino G; Rosa C; Battaglia A; Carena M
Chir Ital; 2004; 56(3):383-8. PubMed ID: 15287635
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis of endocrine tumors of the duodeno-pancreatic area].
Cadiot G; Mignon M; Gresze
Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S6-14. PubMed ID: 12704287
[No Abstract] [Full Text] [Related]
34. [Management of patients with non-functioning gastroentero-pancreatic neuroendocrine tumours].
Guarnieri A; Tirone A; Pallucca E; Testa M; Piccolomini A; Vuolo G; Savelli V; Di Cosmo L; Verre L; Carli AF
Chir Ital; 2006; 58(3):389-96. PubMed ID: 16845879
[TBL] [Abstract][Full Text] [Related]
35. [Treatment strategy of neuroendocrine tumors].
Ducreux M; Baudin E; Schlumberger M
Rev Prat; 2002 Feb; 52(3):290-6. PubMed ID: 11925720
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of functioning pancreaticoduodenal neuroendocrine tumors.
Imamura M; Nakamoto Y; Uose S; Komoto I; Awane M; Taki Y
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):602-9. PubMed ID: 25624017
[TBL] [Abstract][Full Text] [Related]
37. Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours.
Stridsberg M; Eriksson B; Lundqvist G; Skogseid B; Wilander E; Oberg K
Regul Pept; 1995 Jan; 55(2):119-31. PubMed ID: 7754100
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production: a case report and review of literature.
Patel FB; Khagi S; Daly KP; Lechan RM; Ummaritchot V; Saif MW
Anticancer Res; 2013 Sep; 33(9):4001-5. PubMed ID: 24023341
[TBL] [Abstract][Full Text] [Related]
39. Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours.
Ramundo V; Del Prete M; Marotta V; Marciello F; Camera L; Napolitano V; De Luca L; Circelli L; Colantuoni V; Di Sarno A; Carratù AC; de Luca di Roseto C; Colao A; Faggiano A;
Clin Endocrinol (Oxf); 2014 Jun; 80(6):850-5. PubMed ID: 24443791
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis of pancreatic neuroendocrine tumor and medical treatment of endocrine symptoms].
Takano K
Nihon Rinsho; 2015 Mar; 73 Suppl 3():363-7. PubMed ID: 25857049
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]